Zealand Pharma Announces Key Participation in Upcoming Events
Zealand Pharma Engages in Major Healthcare Conferences
Zealand Pharma A/S (Nasdaq: ZEAL), a dynamic biotechnology firm, is stepping into the spotlight as it prepares for a series of healthcare investor conferences in the coming months. This commitment to engage with the healthcare investment community underscores Zealand's strategy to showcase its innovative peptide-based medicines and advancements in drug development.
Conferences Schedule
The anticipated events include a variety of forums where company executives will share insights, present findings, and engage with investors. The lineup includes notable conferences that take place in some of the world's leading cities.
Bank of America Global Healthcare Conference
One of the first events is the Bank of America Global Healthcare Conference happening between May 13 and 15. During this prestigious gathering in Las Vegas, Dr. David Kendall, the Executive Vice President and Chief Medical Officer of Zealand Pharma, is scheduled to deliver a presentation on May 14. Investors can look forward to gaining valuable insights from his expertise as he speaks at 8:00 AM PT.
Berenberg European Conference
Following that, on May 20 through 22, the Berenberg European Conference will take place in New York, where Adam Steensberg, the President and CEO, will host investor meetings, offering a tailored opportunity to discuss the company's future endeavors.
Barclays European Leadership Conference
Another key point on the calendar is the Barclays European Leadership Conference in London on May 22. Dr. Kendall will participate in a panel discussion focusing on crucial topics related to obesity, set for 11:30 AM UK Time.
Jefferies Global Healthcare Conference
As June approaches, Zealand Pharma will continue its active involvement at the Jefferies Global Healthcare Conference from June 3 to 5 in New York. On June 5, Anna Krassowska, Vice President of Investor Relations & Corporate Communications, will join a fireside chat at 11:40 AM ET, providing further context about the company's developments.
Goldman Sachs Annual Global Healthcare Conference
Finally, Zealand will make its presence known at the Goldman Sachs Annual Global Healthcare Conference taking place from June 9 to 11 in Miami. Adam Steensberg is set to engage in a fireside chat on June 11, highlighting what the company has achieved and its future direction.
Company Overview
Zealand Pharma has made significant strides in the field of biotechnology since its inception in 1998. Based in Copenhagen, the company focuses on the discovery and development of innovative peptide-based medicines. Currently, over ten drug candidates have progressed into clinical development, with two successful products already on the market and three more positioned for late-stage development.
Zealand’s collaborations with various pharmaceutical companies enhance its outreach and capabilities in the healthcare sector, making it a member of a competitive and evolving industry. Interested parties can find detailed information on Zealand's ongoing projects and initiatives by visiting their official website.
Company Contacts
For those looking to reach out for more information regarding investor relations, the following contacts are available:
Adam Lange
Vice President, Investor Relations
Email: alange@zealandpharma.com
Neshat Ahmadi
Investor Relations Manager
Email: neahmadi@zealandpharma.com
Anna Krassowska, PhD
Vice President, Investor Relations & Corporate Communications
Email: akrassowska@zealandpharma.com
Frequently Asked Questions
What is Zealand Pharma known for?
Zealand Pharma specializes in the discovery and development of peptide-based medicines, focusing on innovative treatment solutions.
When will Zealand Pharma present at the conferences?
David Kendall will present at the Bank of America Global Healthcare Conference on May 14, with other executives participating in subsequent conferences.
Where are the upcoming conferences located?
The conferences are scheduled to take place in Las Vegas, New York, London, and Miami.
How can investors learn about Zealand Pharma's progress?
Investors can stay informed by attending the conferences and visiting Zealand Pharma's official website for updates on their developments.
What partnerships does Zealand Pharma have?
Zealand Pharma has multiple development and commercial partnerships with leading pharmaceutical companies to advance its marketed products and drug candidates.
About The Author
Contact Dominic Sanders privately here. Or send an email with ATTN: Dominic Sanders as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
